OWL Oncology Research®, a Functional Service Provider (FSP), is a global network of hundreds of experienced clinical research experts specializing in oncology and rare disease trial monitoring, management, consulting and oversight. We deliver the highest quality clinical trial services to the pharmaceutical and biotechnology industries. Our commitment is to ensure that your clinical trials are conducted effectively and efficiently so that new and promising treatments become available to the millions of people battling these diseases. We are committed to facilitating the growing development needs of biotechnology companies in a world where increasingly, large conglomerated contract research organizations (CRO) are defining industry standards for clinical research. These CRO-defined "standards" are often excessive, or even at odds with current regulatory and international guidance, resulting in tangential focus, misleading project scopes, and unnecessary costs. It is our standard and privilege to ensure that new, promising oncology therapeutics are granted the attention, respect, and experienced teams that they deserve, without the cost or intimidation of a large CRO.
